These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31006051)

  • 1. A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture.
    Kharazmi M; Michaëlsson K; Schilcher J; Eriksson N; Melhus H; Wadelius M; Hallberg P
    Calcif Tissue Int; 2019 Jul; 105(1):51-67. PubMed ID: 31006051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of bisphosphonate-associated femoral fractures.
    Shkolnikova J; Flynn J; Choong P
    ANZ J Surg; 2013 Mar; 83(3):175-81. PubMed ID: 23216704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.
    Chang ST; Tenforde AS; Grimsrud CD; O'Ryan FS; Gonzalez JR; Baer DM; Chandra M; Lo JC
    Bone; 2012 Sep; 51(3):524-7. PubMed ID: 22634175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.
    Meier RP; Perneger TV; Stern R; Rizzoli R; Peter RE
    Arch Intern Med; 2012 Jun; 172(12):930-6. PubMed ID: 22732749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and associated factor of atypical periprosthetic femoral fracture after hip arthroplasty.
    Lee YK; Park CH; Kim KC; Hong SH; Ha YC; Koo KH
    Injury; 2018 Dec; 49(12):2264-2268. PubMed ID: 30245278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry.
    Hagen JE; Miller AN; Ott SM; Gardner M; Morshed S; Jeray K; Alton TB; Ren D; Abblitt WP; Krieg JC
    J Bone Joint Surg Am; 2014 Nov; 96(22):1905-9. PubMed ID: 25410509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up.
    Png MA; Mohan PC; Koh JSB; Howe CY; Howe TS
    Osteoporos Int; 2019 Dec; 30(12):2417-2428. PubMed ID: 31435684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bisphosphonate-associated atypical fractures of the femur: an update of the current evidence].
    Kharazmi M; Schilcher J; Hallberg P; Michaëlsson K
    Lakartidningen; 2019 Sep; 116():. PubMed ID: 31529420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.
    Lenart BA; Neviaser AS; Lyman S; Chang CC; Edobor-Osula F; Steele B; van der Meulen MC; Lorich DG; Lane JM
    Osteoporos Int; 2009 Aug; 20(8):1353-62. PubMed ID: 19066707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.
    Thompson RN; Phillips JR; McCauley SH; Elliott JR; Moran CG
    J Bone Joint Surg Br; 2012 Mar; 94(3):385-90. PubMed ID: 22371548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
    Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
    Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atypical femoral fracture associated with the use of bisphosphonates, an adverse drug reaction not to be missed].
    Ing Lorenzinit K; Meier R; Suva D; Dayer P; Desmeules J; Peter R
    Rev Med Suisse; 2012 Jun; 8(344):1238-42. PubMed ID: 22730621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Risk Factors for Bisphosphonate-Associated Atypical Femoral Fractures and Osteonecrosis of the Jaw in a Pharmacovigilance Database.
    Bejhed RS; Kharazmi M; Hallberg P
    Ann Pharmacother; 2016 Aug; 50(8):616-24. PubMed ID: 27179251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare non-traumatic periprosthetic femoral fracture with features of an atypical femoral fracture: a case report.
    Niikura T; Lee SY; Sakai Y; Kuroda R; Kurosaka M
    J Med Case Rep; 2015 May; 9():103. PubMed ID: 25943378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of atypical femoral fracture during and after bisphosphonate use.
    Schilcher J; Koeppen V; Aspenberg P; Michaëlsson K
    Acta Orthop; 2015 Feb; 86(1):100-7. PubMed ID: 25582459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
    Park KT; Lee KB
    Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features.
    Giusti A; Hamdy NA; Dekkers OM; Ramautar SR; Dijkstra S; Papapoulos SE
    Bone; 2011 May; 48(5):966-71. PubMed ID: 21195812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study.
    Eisenstein N; Kasavkar G; Bhavsar D; Khan FS; Paskins Z
    BMC Musculoskelet Disord; 2017 Jan; 18(1):29. PubMed ID: 28114975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical femoral fractures related to bisphosphonate use: A comprehensive review of 19 patients.
    Şahin K; Ergin ON; Bayram S; Akgül T
    Ulus Travma Acil Cerrahi Derg; 2019 Nov; 25(6):603-610. PubMed ID: 31701502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate-related atypical femoral fracture: Managing a rare but serious complication.
    Silverman S; Kupperman E; Bukata S
    Cleve Clin J Med; 2018 Nov; 85(11):885-893. PubMed ID: 30395525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.